Skip to main content
Premium Trial:

Request an Annual Quote

Invitae, Outcomes4Me Collaborate to Improve Breast Cancer Genetic Testing Access

NEW YORK – Outcomes4Me, an oncology-focused mobile app developer, on Thursday said it is working with molecular testing firm Invitae to improve education and access to genetic testing for breast cancer patients and survivors.

Patients can currently order genetic testing to assess their cancer risk through Invitae, receive genetic counseling through Invitae's partner Genome Medical, and once test results are available, upload them to Outcomes4Me's app. The latest partnership will now allow patients to make a genetic counseling appointment and order testing directly from Outcomes4Me's platform. Patients can authorize Invitae to report test results directly to the Outcomes4Me platform, within which they can also create a clinical profile.

The results integration with the Outcomes4Me platform will improve users' access to evidence-based information on treatment options and clinical trial eligibility, and inform how updated treatment and testing guidelines might impact their care.

Studies have shown that the healthcare system is currently failing to identify a large swath of individuals who qualify for genetic cancer risk assessments based on current guidelines. According to Outcomes4Me's patient data, almost half of its users who qualified for testing based on the National Comprehensive Cancer Network's guidelines hadn't been tested or did not know if they had received testing.

The collaboration with Outcomes4Me supports Invitae's ongoing efforts to increase access to genetic testing. "By providing access to our comprehensive genetic testing and counseling services, Outcomes4Me is adding a valuable resource that will empower patients to advance their knowledge, understanding, and therefore, self-advocacy during treatment and survivorship," Ed Esplin, a clinical geneticist at Invitae, said in a statement.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.